RIBOMIC INCRIBOMIC INCRIBOMIC INC

RIBOMIC INC

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪3.26 B‬JPY
−26JPY
‪−1.02 B‬JPY
0.00JPY
‪39.05 M‬
Beta (1Y)
0.83
Employees (FY)
24
Change (1Y)
−1 −4.00%
Revenue / Employee (1Y)
0.00JPY
Net income / Employee (1Y)
‪−42.68 M‬JPY

About RIBOMIC INC


Headquarters
Tokyo
Founded
2003
ISIN
JP3974850004
FIGI
BBG0070P8D92
RIBOMIC, Inc. engages in the research and development of molecular targeted drugs using Ribonucleic Acid (RNA) aptamers for use in therapeutic fields. It utilizes the Ribomic Aptamer Therapeutics (RiboART) system to discover new drugs that are applicable to target proteins. The company was founded by Yoshikazu Nakamura on August 1, 2003 and is headquartered in Tokyo, Japan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 4591 is 80 JPY — it has decreased by −1.25% in the past 24 hours. Watch RIBOMIC INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange RIBOMIC INC stocks are traded under the ticker 4591.
4591 stock has fallen by −2.47% compared to the previous week, the last month showed zero change in price, over the last year RIBOMIC INC has showed a −23.81% decrease.
4591 reached its all-time high on Sep 25, 2014 with the price of 2,078 JPY, and its all-time low was 60 JPY and was reached on Aug 5, 2024. View more price dynamics on 4591 chart.
See other stocks reaching their highest and lowest prices.
4591 stock is 2.53% volatile and has beta coefficient of 0.83. Track RIBOMIC INC stock price on the chart and check out the list of the most volatile stocks — is RIBOMIC INC there?
Yes, you can track RIBOMIC INC financials in yearly and quarterly reports right on TradingView.
RIBOMIC INC is going to release the next earnings report on Feb 7, 2025. Keep track of upcoming events with our Earnings Calendar.
4591 net income for the last quarter is ‪−225.14 M‬ JPY, while the quarter before that showed ‪−254.76 M‬ JPY of net income which accounts for 11.63% change. Track more RIBOMIC INC financial stats to get the full picture.
No, 4591 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 19, 2024, the company has 24.00 employees. See our rating of the largest employees — is RIBOMIC INC on this list?
Like other stocks, 4591 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RIBOMIC INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RIBOMIC INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RIBOMIC INC stock shows the sell signal. See more of RIBOMIC INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.